Below is your **complete, advanced, exam-ready, all-in-one COVID-19 medical note** written in your preferred **complete-reference pattern**: **definition → pathophysiology → transmission → viral variants → clinical features → investigations → diagnosis → DDx → complications → full management (stepwise) → pharmacology of each drug (MOA, indication, dose, PK, ADRs, CI, monitoring, counselling) → prevention → vaccines.** --- # 🦠 **COVID-19 — Complete Advanced Medical Reference (NEETPG/Clinical)** --- # **1. Definition** COVID-19 is an acute viral disease caused by **SARS-CoV-2**, an enveloped, positive-sense **RNA coronavirus**. It ranges from asymptomatic infection to severe viral pneumonia, ARDS, sepsis, and multi-organ dysfunction. --- # **2. Virology & Pathophysiology** ### **Virus** * Betacoronavirus, 29–30 kb RNA genome. * Structural proteins: **S (spike), E, M, N**. * S-protein binds **ACE2** receptors + TMPRSS2 facilitates entry. ### **Host entry & organ tropism** ACE2 found in: * Type II alveolar cells * Myocardium * Endothelium * GI mucosa * Kidney proximal tubules * CNS ### **Phases of disease** 1. **Early Viral Replication Phase** (Days 1–5) → Viral replication high; symptoms mild; antivirals useful. 2. **Pulmonary Phase** (Days 5–10) → Viral + immune injury → pneumonia → hypoxia. 3. **Hyper-inflammatory Phase / Cytokine storm** (Days 10–14) → IL-6, IL-1β, TNF-α surge → ARDS, shock, thrombosis. ### **Immune Pathogenesis** * Dysregulated innate immunity * Delayed interferon response * Hyper-inflammation * **Endothelialitis + microvascular thrombosis** (↑ D-dimer) * **Hypercoagulable state** --- # **3. Modes of Transmission** * Respiratory droplets, aerosols * Fomites (less common) * Close contact * Vertical transmission rare * Highest contagious period: **2 days before and 3 days after symptom onset**. --- # **4. Variants (Updated Classification)** * **Alpha, Beta, Gamma** — earlier waves * **Delta** — more severe, high hospitalization * **Omicron (BA.1 → BA.5, XBB, BQ, JN.1)** — highly transmissible, less severe, immune evasion * **Current dominant lineages (global): Omicron sublineages** with high reinfection capability. --- # **5. Clinical Features** ### **Asymptomatic:** ~30–40% ### **Mild (Upper respiratory)** * Fever, dry cough * Sore throat * Anosmia/ageusia * Rhinorrhea * Myalgia, fatigue ### **Moderate** * Pneumonia with **SpO₂ ≥ 94%** * Dyspnea * Persistent fever ### **Severe** * **SpO₂ < 94%** * RR ≥ 30/min * Lung infiltrates > 50% * Respiratory distress ### **Critical** * ARDS * Septic shock * Multi-organ dysfunction * Acute cardiac injury * Acute kidney injury ### **Complications** * ARDS * Cytokine storm * Microthrombosis, DVT, PE * MIS-C (children) * Myocarditis * Acute liver injury * Long COVID (fatigue, dyspnea, cognitive dysfunction) --- # **6. Investigations** ### **Baseline** * CBC: lymphopenia * CRP: ↑ * D-dimer: ↑ * Ferritin: ↑ * LDH: ↑ * LFT, RFT * ABG (if hypoxic) ### **Radiology** **HRCT chest findings**: * Bilateral peripheral **ground-glass opacities** * Crazy-paving pattern * Patchy consolidation * CT Severity Score (CSS) used for monitoring ### **Diagnostic Tests** * **RT-PCR (gold standard)** * Genes: RdRp, N, E * Ct < 25 → high viral load * **Rapid Antigen Test** (moderate sensitivity) * **Serology IgM/IgG** (past infection) --- # **7. Differential Diagnosis** * Influenza * RSV * Adenovirus pneumonia * Bacterial pneumonia * Pulmonary embolism * Heart failure * Other viral pneumonias (CMV, H1N1) --- # **8. Management (Stepwise)** --- # 🟢 **A. Mild COVID-19 (Home Care)** * Paracetamol * Hydration * Pulse oximeter monitoring * Zinc (optional) * Avoid steroids * **Antivirals only for high-risk** (elderly, comorbid, immunosuppressed): * **Nirmatrelvir + Ritonavir (Paxlovid)** * **Remdesivir (early 3-day outpatient regimen)** --- # 🟡 **B. Moderate (SpO₂ ≥ 94% but pneumonia present)** * **Oxygen if required** (target 92–96%) * **Steroids: Dexamethasone 6 mg/day** * **Remdesivir** * **Anticoagulation: Enoxaparin prophylactic dose** * Monitor: * CRP, D-dimer * RR, SpO₂ trends * Chest imaging if worsening --- # 🔴 **C. Severe / Critical COVID-19** ### **1. Respiratory** * Oxygen: NRBM → HFNC → NIV * Intubation for refractory hypoxia * Proning (awake & ventilated) ### **2. Anti-inflammatory** * Dexamethasone 6 mg IV/PO x 10 days * **Tocilizumab** (IL-6 inhibitor) for cytokine storm * Baricitinib (JAK inhibitor) when Tocilizumab unavailable ### **3. Anticoagulation** * **Therapeutic enoxaparin** in high D-dimer or suspected thrombosis * Avoid if bleeding risk ### **4. Antivirals** * Remdesivir (if < 10 days from symptom onset) * Paxlovid (early disease only) ### **5. Organ Support** * Vasopressors * Renal replacement therapy * ECMO in selected cases --- # **9. Pharmacology of Key Drugs** *(Indication, MOA, Dosage, PK, ADRs, Contra, Monitoring, Counselling)* --- ## **A. Remdesivir** **Indication:** Moderate–severe COVID (within 10 days of symptoms) **MOA:** RNA-dependent RNA polymerase inhibitor **Dose:** * 200 mg IV day 1 → 100 mg IV daily × 5 days **PK:** Hepatic metabolism; renal elimination **ADRs:** LFT elevation, bradycardia **Contra:** GFR < 30 ml/min **Monitoring:** LFT, renal function **Counselling:** Report palpitations, yellowing of eyes. --- ## **B. Dexamethasone** **Indication:** Hypoxic COVID **MOA:** Corticosteroid → suppresses cytokine storm **Dose:** 6 mg/day PO/IV (max 10 days) **ADRs:** Hyperglycemia, secondary infection, GI bleed **Contra:** Uncontrolled diabetes, active fungal infection **Monitoring:** RBS, BP, sepsis signs **Counselling:** Take with food, watch for fever/worsening cough. --- ## **C. Tocilizumab** **Indication:** Severe COVID with high IL-6/CRP **MOA:** IL-6 receptor blocker **Dose:** 8 mg/kg IV single dose (max 800 mg) **ADRs:** Hepatitis, neutropenia, bowel perforation **Contra:** Sepsis, TB **Monitoring:** LFT, CBC, CRP **Counselling:** Report abdominal pain, jaundice. --- ## **D. Nirmatrelvir + Ritonavir (Paxlovid)** **Indication:** High-risk mild/moderate COVID **within 5 days** **MOA:** 3CL protease inhibition + ritonavir boosting **Dose:** 300 mg/100 mg BID × 5 days **PK:** CYP3A4 inhibition (many interactions!) **ADRs:** Dysgeusia, diarrhea **Contra:** Statins, antiarrhythmics, immunosuppressants **Monitoring:** Drug interactions, renal function **Counselling:** Bitter taste normal; keep hydration. --- ## **E. Enoxaparin** **Indication:** Hypercoagulability in COVID **MOA:** Inhibits factor Xa **Dose:** * Prophylactic: 40 mg SC daily * Therapeutic: 1 mg/kg SC BID **ADRs:** Bleeding, HIT **Contra:** Active bleeding **Monitoring:** Platelets, PT/aPTT **Counselling:** Look for bruising. --- # **10. MIS-C (Children)** * Persistent fever * Multisystem inflammation * Rash, shock, myocarditis **Treatment:** IVIG + steroids + aspirin. --- # **11. Long COVID** Symptoms > 12 weeks: * Fatigue * Breathlessness * Brain fog * Autonomic dysfunction * Depression/anxiety **Management:** Rehab, pulmonary exercises, sleep hygiene, CBT if needed. --- # **12. Prevention** ### **General** * Masks * Ventilation * Hand hygiene * Avoid crowded indoor spaces ### **Vaccination** Approved platforms: * mRNA (Pfizer, Moderna) * Viral vector (Covishield, AstraZeneca, J&J) * Inactivated (Covaxin, Sinopharm) * Protein subunit (Novavax) **Booster indicated** for elderly, comorbid, immunocompromised. --- # **13. Key Exam Pearls** * **RT-PCR Ct value does NOT correlate with severity.** * **Steroids only in hypoxia.** * **Remdesivir not useful late (>10 days).** * **Tocilizumab only with high inflammatory markers.** * **High D-dimer is a poor prognostic marker.** * **Omicron → less LRT disease but high reinfection rates.** --- If you want, I can also generate: ✅ **Case scenarios (10–50)** ✅ **Hard MCQs (HTML + CSS + JS in one file)** ✅ **Tags for your NEETPG hub** ✅ **Image/diagram on COVID pathophysiology** Just tell me: **“Give case scenarios” / “Give MCQs file” / “Give tags” / “Create image”**.